Home › Cancro del polmone non a piccole cellule › Iowa › Cedar Rapids
Studi clinici su Cancro del polmone non a piccole cellule a Cedar Rapids, IA
20 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Cedar Rapids e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
In reclutamentoFase 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
In reclutamentoFase 3
- University of Iowa Hospitals & Clinics, Iowa City · a 25 mi di distanza
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Local Institution - 0065, Iowa City · a 25 mi di distanza
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
In reclutamentoFase 2/3
- Physicians Clinic of Iowa, Cedar Rapids
- Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City · a 25 mi di distanza
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
In reclutamentoFase 3
- Mercy Medical Center, Cedar Rapids
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
In reclutamentoFase 1
- University of Iowa Hospital and Clinics, Iowa City · a 25 mi di distanza
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
In reclutamentoFase 1
- University of Iowa, Iowa City · a 25 mi di distanza
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
In reclutamentoFase 3
- University of Iowa, Iowa City · a 25 mi di distanza
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
In reclutamentoFase 1/2
- University of Iowa Hospitals & Clinics PARENT, Iowa City · a 25 mi di distanza
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- University of Iowa, Iowa City · a 25 mi di distanza
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
In reclutamentoFase 1
- University of Iowa, Iowa City · a 25 mi di distanza
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
In reclutamentoFase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
In reclutamentoFase 1
- University of Iowa Health Care, Iowa City · a 25 mi di distanza
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
In reclutamentoFase 1
- University of Iowa Hospitals & Clinics, Iowa City · a 25 mi di distanza
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
In reclutamentoFase 2
- University of Iowa Hospitals and Clinics, Iowa City · a 25 mi di distanza
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · a 25 mi di distanza
GEMINI-NSCLC: NSCLC Biomarker Study
In reclutamentoStudio osservazionale
- University of Iowa, Iowa City · a 25 mi di distanza
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Iowa City · a 25 mi di distanza
Test-retest Evaluation of [18F]F-AraG PET
In reclutamentoFase 2
- University of Iowa Hospitals and Clinics, Iowa City · a 25 mi di distanza
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY120 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH56 studi
- Washington, DC55 studi
Altri studi a Cedar Rapids
- Cancro al seno17 studi
- Leucemia mieloide acuta16 studi
- Cancro (tutti i tipi)15 studi
- Mieloma multiplo15 studi
- Cancro ai polmoni14 studi
- Cancro colorettale13 studi
- Cancro alla prostata12 studi
- Carcinoma a cellule squamose della testa e del collo12 studi
- Melanoma10 studi
- Ictus10 studi
- Cancro metastatico9 studi
- Cancro dell'endometrio9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.